20th Anniversary of Indy Hematology Review

20th Annual Indy Hematology ReviewTM

Saturday, March 18th 2023 | 7:00 am – 8:30 pm The Westin Indianapolis

Indy Hematology Review Supporters

2023 Symposium Agenda

Saturday, March 18th 2023

6:00 – 10:00 AM

REGISTRATION

7:00-7:45 AM

PRODUCT THEATER

7:00-4:00 PM

Exhibit Displays

SESSION CHAIR: Dr. Ruemu E. Birhiray, MD

8:00-8:30 AM

State of the Art: 2023: Emerging Therapies in Hematologic Malignancies

Dr. Ruemu E. Birhiray, MD

8:30 - 9:00 AM

Improving Outcomes with Current Therapies in Acute Myeloid Leukemia and Acute Promyelocytic Leukemia: What we Recommend in 2023

Dr. Martin Tallman, MD

 

9:00 - 9:30 AM

Apollo and The Indianapolis Oracle: Prognostication and Treatment of Myelodysplastic Syndromes

Dr. Richard Stone, MD

9:30 - 10:00 AM

Controversies in the Management of Chronic Myeloid Leukemia:
Treatment Goals in CML: Fast and Deep and Aiming to Stop Therapy in CML

Dr. Harry P. Erba, MD, PhD

Rescuing and Treating the Relapsed Patient with CML

Dr. Richard Larson, MD

10:00 – 10:15 AM

COFFEE BREAK – EXHIBIT HALL

10:15-10:45 AM

Emerging and Current Treatment of Multiple Myeloma: What Should We Know and What Should We Do

Dr. Kenneth Anderson, MD

10:45 –11:15 AM

Beyond Hyperviscosity: 80 Years and Counting, Treatment of Waldenstrom’s Macroglobulinemia

Dr. Steven Treon, MD, MA, PhD, FACP, FRCP

11:15 -11:45 AM

Managing the Benign Hematology Consult: Treatment Recommendations for Coagulopathy, Cytosis and Cytopenia

Dr. Craig Kessler, MD

11:45 AM - 12:00 PM

COFFEE BREAK – EXHIBIT HALL

12:00 -12:30 PM

When Too Much is Not Desirable: Diagnosis and Treatment of Cellular Disorders of the Blood, Polycythemia Vera, Essential Thrombocytosis and Mastocytosis

Dr. Ayalew Tefferi, MD

12:30 -1:00 PM

Myelofibrosis, Philadelphia Chromosome Negative Myeloproliferative and FGFR Mutant Myeloid Neoplasms

Dr. Srdan Verstovsek, MD, PhD

1:00 – 1:45 PM

LUNCH AND PRODUCT THEATERS

1:45 - 2:00 PM

COFFEE BREAK – EXHIBIT HALL

SESSION CHAIR: Dr. Michael Wiemann, MD, FACP

2:00 – 2:45 PM

T. Howard Lee Keynote Lecture:
20 Years of Indy Hematology Review and The Cure is in: Managing Indolent and Mantle Cell Lymphomas with Targeted and Cellular Therapies in 2023

Dr. Gilles Salles, MD, PhD

2:45 – 3:15 PM

Current Controversies and Recommendations for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: The Indy Hematology Review Recommendations for 2023

3:15 – 3:45 PM

Emerging Therapy for Relapsed and Refractory Chronic Lymphocytic Leukemia

Dr. William Wierda, MD, PhD

3:45 – 4:00 PM

COFFEE BREAK – EXHIBIT HALL

4:00 – 4:30 PM

Annual Steven Coutre Chronic Lymphocytic Leukemia Memorial Lecture: Therapeutic Options in CLL in 2023: Choosing Wisely: Initial Therapy in CLL

Dr. Jennifer Woyach, MD

4:30 – 5:00 PM

Jumping On a Moving Train: Emerging and Current Treatment Hodgkin’s Lymphomas.

5:00 – 5:30 PM

Advancing Therapeutic Outcomes in Aggressive B and T Cell Lymphomas

5:30 – 6:00 PM

Hematopoietic Transplantation and Cellular Therapies

Dr. Richard Childs, MD

6:00- 6:30 PM

The Great Debate: Controversies in The Initial Therapy of Multiple Myeloma: To Transplant or Not When Minimal Residual Disease has been Achieved as Initial Therapy for Multiple Myeloma
Monitoring and Rescuing the MRD Negative Patient with Multiple Myeloma After Initial Therapy

Dr. Saad Usmani, MD, MBA, FACP

Transplanting the MRD Negative Myeloma Patients for a Deeper Remission After Initial Therapy

Dr. Joseph Mikhael MD, MEd, FRCPC, FACP

6:30 –7:00 PM

Q/A and Panel Discussion – Take Home Messages: Achieving Tomorrow’s Outcomes Through Education Today

Dr. Ruemu E. Birhiray, MD – Chair and Moderator
Dr. Michael Wiemann, MD, FACP – Co-Chair

Chronic Lymphocytic Leukemia
Dr. Rami Komrokji, MD: Chronic Myeloid Leukemia
Dr. Rubin Mesa, MD, FACP: Myeloproliferative Neoplasms
Dr. Charles Schiffer, MD: Acute Leukemias and Myelodysplastic Syndromes
Dr. Morie Gertz, MD, MACP: Plasma Cell Neoplasms and Amyloidosis

7:00 – 7:30 PM

 Hors D’oeuvres

7:30 - 8:45 PM

Hematologic Malignancies Townhall

Dr. Ruemu E. Birhiray, MD – Chair and Moderator
Dr. Michael Wiemann, MD, FACP – Co-Chair

Ruemu E. Birhiray, MD – Chair and Moderator
Michael Wiemann, MD, FACP – Co-Chair
Morie Gertz, MD, MACP – Plasma Cell Disorders and Amyloidosis
Jennifer Woyach, MD – Chronic Lymphocytic Leukemia
Rami Komrokji, MD – Acute Leukemias and Myelodysplastic Syndromes
Rubin Mesa, MD, FACP – Myeloproliferative Neoplasms
Lymphomas
Saad Usmani, MD, MBA, FACP – Multiple Myeloma
Charles Schiffer, MD Leukemias and Myelodysplastic Syndromes
Joseph Mikhael, MD, MEd, FRCPC, FACP – Multiple Myeloma

Nursing and Allied Providers Symposium Agenda

Moderators: Donna M. Birhiray, OTR, MBA & Thalia Hammond

8:00 AM

Kick-Off Nursing Symposium

Dr. Ruemu E. Birhiray, MD

8:40 – 9:05 AM

Understanding and Managing Immune Effector Toxicities in Hematologic Toxicities

David Reeves, PharmD, BCOP

9:05 – 9:30 AM

Management of Long-Term Survivors of Hematologic Malignancies

Sandra Garofalo, MS, APRN, AOCNP

9:30 –10:00 AM

Managing Disorders of the Benign Hematology Patient

Dr. Craig Kessler, MD

10:00 - 10:15AM

COFFEE BREAK – EXHIBIT HALL

10:15 – 10:45 AM

Understanding the Diagnosis and Treatment of Plasma Cell Disorders

Dr. Saad Usmani, MD, MBA, FACP

10:45 – 11:15 AM

Emerging and Current Treatment of Amyloidosis and Waldenstrom’s Macroglobulinemia

Dr. Morie Gertz, MD, MACP

11:15 – 11:30 AM

COFFEE BREAK – EXHIBIT HALL

11:30 – 11:55 AM

Recognizing Toxicities of Oral Oncolytics in the Management of Hematologic Malignancies

Kristi Orbaugh RN, MSN, RNP, AOCN

11:55 – 12:25 PM

Diagnosis and Treatment of Myeloproliferative Neoplasms

Dr. Ruben Mesa, MD, FACP

12:25 – 12:55 PM

Current and Emerging Therapies for Acute Leukemias and Myelodysplastic Syndromes

Dr. Richard Larson, MD

12:55 – 1:00 PM

Q & A Session

1:00 PM

LUNCH AND PRODUCT THEATERS

2:00 PM

ALL JOIN MAIN SYMPOSIUM